{
  "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549",
  "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb",
  "documentTitle": "Erasca | Investor Presentation Deck | 41 slides",
  "authorId": "erasca",
  "authorName": "Erasca",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 38,
  "pageCount": 41,
  "prevPage": 37,
  "nextPage": 39,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide uses a two-column layout (Preclinical vs Clinical) to position the company's lead asset against competitors.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/38",
  "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549",
  "deckJsonHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549.json",
  "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-38",
  "components": [
    {
      "bbox": {
        "h": 0.8,
        "w": 0.6,
        "x": 0.02,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Preclinical vs Clinical landscape",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8bc9b46-4fff-4f54-9ee0-399616f49b89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.38,
        "x": 0.61,
        "y": 0.2
      },
      "kind": "list",
      "text": "Most advanced pan-RAF inhibitor; PoC established; Strong complementarity with Erasca pipeline",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "443b1190-5a91-4891-9f48-17ff208b9628",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.38,
        "x": 0.61,
        "y": 0.78
      },
      "kind": "source-note",
      "text": "1 Belvarafenib is also being evaluated... 2 NDA has been accepted... 3 Exarafenib in Ph 1b... ORR: overall response rate; SOC: standard of care; PoC: proof-of-concept",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "835f621a-7e9b-40ab-afc5-9aa58216230d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "Naporafenib: Potential first-in-class pan-RAF inhibitor",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99d90bfa-cc09-4571-958c-0c4bca0b6c09",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "58145c34-b834-43ab-9111-65c3e1c39003",
      "evidence": "list/bullet: Most advanced pan-RAF inhibitor; PoC established; Strong complementarity with Erasca pipeline",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "competitive-landscape",
      "slug": null,
      "matchId": "24605ab1-d975-4b7b-8ee2-36882660ed5a",
      "evidence": "Comparison of clinical assets across industry peers",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 38,
      "from": 31,
      "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Market Sizing",
      "beatSlug": null,
      "evidence": "Estimating the market potential of Erasca's treatments",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}